Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
Outline of Final Research Achievements |
Coffin-Siris syndrome (CSS; MIM 135900), first described by Coffin and Siris in 1970, is a congenital disorder characterized by intellectual disability, growth deficiency, microcephaly, coarse facial features, and hypoplastic or absent fifth fingernails and/or toenails. The majority of affected individuals represent sporadic cases. In the all patients, 88 out of 148 CSS patients (59.5 %) carry a mutation in one of five genes encoding a BAF complex subunit or SOX11; SMARCB1 (10 of 148 patients, 6.8 %), SMARCA4 (14 of 148 patients, 9.5 %), SMARCE1 (2 of 148 patients, 1.4 %), ARID1A (6 of 148 patients, 4.1 %), ARID1B (54 of 148 patients, 36.5 %) or SOX11 (2 of 148 patients, 1.4 %).
|